Bares Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bares Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,834	Closed	-$226K	–	14
2014 Q4	$226K	Buy	+3,834	New	+$216K	0.03%	48
2014 Q1	–	Sell	-3,834	Closed	-$204K	–	70
2013 Q4	$204K	Buy	+3,834	New	+$195K	0.02%	63

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bares Capital Management's BMY Position: Q1 2015 in Review

Bares Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2015, closing a stake of 3,834 shares — an estimated $226K sold.

Bares Capital Management first reported a position in BMY in Q4 2013 and held it in 2 quarters. The position peaked at $226K in Q4 2014. 1,449 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

Bares Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2015 after selling out during the quarter.
Bares Capital Management sold 3,834 Bristol-Myers Squibb shares in Q1 2015, an estimated $226K.
Bares Capital Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 2 quarters.
Bares Capital Management's Bristol-Myers Squibb position peaked at $226K in Q4 2014.
1,449 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Bares Capital Management's 13F filing for Q1 2015, filed 15 May 2015.